These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32935478)

  • 21. IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.
    Sánchez-Fernández A; Zandee S; Amo-Aparicio J; Charabati M; Prat A; Garlanda C; Eisenmesser EZ; Dinarello CA; López-Vales R
    Theranostics; 2021; 11(1):1-13. PubMed ID: 33391457
    [No Abstract]   [Full Text] [Related]  

  • 22. PI3K in cancer: its structure, activation modes and role in shaping tumor microenvironment.
    Liu X; Xu Y; Zhou Q; Chen M; Zhang Y; Liang H; Zhao J; Zhong W; Wang M
    Future Oncol; 2018 Mar; 14(7):665-674. PubMed ID: 29219001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.
    Zhang Y; Davis C; Shah S; Hughes D; Ryan JC; Altomare D; Peña MM
    Mol Carcinog; 2017 Jan; 56(1):272-287. PubMed ID: 27120577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-36β Promotes CD8
    Zhao X; Chen X; Shen X; Tang P; Chen C; Zhu Q; Li M; Xia R; Yang X; Feng C; Zhu X; Zhu Y; Sun Z; Zhang X; Lu B; Wang X
    Front Immunol; 2019; 10():1803. PubMed ID: 31447838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-1 and IL-1 regulatory pathways in cancer progression and therapy.
    Mantovani A; Barajon I; Garlanda C
    Immunol Rev; 2018 Jan; 281(1):57-61. PubMed ID: 29247996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation.
    Li Y; Zhao M; Guo C; Chu H; Li W; Chen X; Wang X; Li Y; Jia Y; Koussatidjoa S; Zhu F; Wang J; Wang X; Wang Q; Zhao W; Shi Y; Chen W; Zhang L
    Oncogene; 2018 Feb; 37(8):1095-1106. PubMed ID: 29106392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The paradox of Th17 cell functions in tumor immunity.
    Asadzadeh Z; Mohammadi H; Safarzadeh E; Hemmatzadeh M; Mahdian-Shakib A; Jadidi-Niaragh F; Azizi G; Baradaran B
    Cell Immunol; 2017 Dec; 322():15-25. PubMed ID: 29103586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights into the role of IL-32 in cancer.
    Sloot YJE; Smit JW; Joosten LAB; Netea-Maier RT
    Semin Immunol; 2018 Aug; 38():24-32. PubMed ID: 29747940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses.
    Wang X; Zhao X; Feng C; Weinstein A; Xia R; Wen W; Lv Q; Zuo S; Tang P; Yang X; Chen X; Wang H; Zang S; Stollings L; Denning TL; Jiang J; Fan J; Zhang G; Zhang X; Zhu Y; Storkus W; Lu B
    Cancer Cell; 2015 Sep; 28(3):296-306. PubMed ID: 26321222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies.
    Gelfo V; Romaniello D; Mazzeschi M; Sgarzi M; Grilli G; Morselli A; Manzan B; Rihawi K; Lauriola M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ST2 Signaling in the Tumor Microenvironment.
    Chang CP; Hu MH; Hsiao YP; Wang YC
    Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth.
    Lyu J; Yang EJ; Head SA; Ai N; Zhang B; Wu C; Li RJ; Liu Y; Yang C; Dang Y; Kwon HJ; Ge W; Liu JO; Shim JS
    Cancer Lett; 2017 Nov; 409():91-103. PubMed ID: 28923401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Swords into plowshares: IL-23 repurposes tumor immune surveillance.
    Langowski JL; Kastelein RA; Oft M
    Trends Immunol; 2007 May; 28(5):207-12. PubMed ID: 17395538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapeutic approaches of IL-1 neutralization in the tumor microenvironment.
    Apte RN; Voronov E
    J Leukoc Biol; 2017 Aug; 102(2):293-306. PubMed ID: 28522598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.
    Li S; Neff CP; Barber K; Hong J; Luo Y; Azam T; Palmer BE; Fujita M; Garlanda C; Mantovani A; Kim S; Dinarello CA
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2497-502. PubMed ID: 25654981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs.
    Hewitt SL; Bai A; Bailey D; Ichikawa K; Zielinski J; Karp R; Apte A; Arnold K; Zacharek SJ; Iliou MS; Bhatt K; Garnaas M; Musenge F; Davis A; Khatwani N; Su SV; MacLean G; Farlow SJ; Burke K; Frederick JP
    Sci Transl Med; 2019 Jan; 11(477):. PubMed ID: 30700577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout.
    Liu L; Xue Y; Zhu Y; Xuan D; Yang X; Liang M; Wang J; Zhu X; Zhang J; Zou H
    Arthritis Res Ther; 2016 Nov; 18(1):268. PubMed ID: 27863506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of IL-37 in skin and connective tissue diseases.
    Pan Y; Wen X; Hao D; Wang Y; Wang L; He G; Jiang X
    Biomed Pharmacother; 2020 Feb; 122():109705. PubMed ID: 31918276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-35 induces N2 phenotype of neutrophils to promote tumor growth.
    Zou JM; Qin J; Li YC; Wang Y; Li D; Shu Y; Luo C; Wang SS; Chi G; Guo F; Zhang GM; Feng ZH
    Oncotarget; 2017 May; 8(20):33501-33514. PubMed ID: 28432279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.